Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 23(13)2022 Jun 29.
Artigo em Inglês | MEDLINE | ID: mdl-35806209

RESUMO

Cancer cells undergo drastic metabolic adaptions to cover increased bioenergetic needs, contributing to resistance to therapies. This includes a higher demand for cholesterol, which often coincides with elevated cholesterol uptake from low-density lipoproteins (LDL) and overexpression of the LDL receptor in many cancers. This implies the need for cancer cells to accommodate an increased delivery of LDL along the endocytic pathway to late endosomes/lysosomes (LE/Lys), providing a rapid and effective distribution of LDL-derived cholesterol from LE/Lys to other organelles for cholesterol to foster cancer growth and spread. LDL-cholesterol exported from LE/Lys is facilitated by Niemann-Pick Type C1/2 (NPC1/2) proteins, members of the steroidogenic acute regulatory-related lipid transfer domain (StARD) and oxysterol-binding protein (OSBP) families. In addition, lysosomal membrane proteins, small Rab GTPases as well as scaffolding proteins, including annexin A6 (AnxA6), contribute to regulating cholesterol egress from LE/Lys. Here, we summarize current knowledge that links upregulated activity and expression of cholesterol transporters and related proteins in LE/Lys with cancer growth, progression and treatment outcomes. Several mechanisms on how cellular distribution of LDL-derived cholesterol from LE/Lys influences cancer cell behavior are reviewed, some of those providing opportunities for treatment strategies to reduce cancer progression and anticancer drug resistance.


Assuntos
Antineoplásicos , Neoplasias , Antineoplásicos/análise , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Colesterol/metabolismo , LDL-Colesterol/metabolismo , Endossomos/metabolismo , Humanos , Lisossomos/metabolismo , Neoplasias/tratamento farmacológico , Neoplasias/metabolismo , Proteína C1 de Niemann-Pick/metabolismo , Proteínas rab de Ligação ao GTP/metabolismo
2.
Hum Mol Genet ; 31(9): 1500-1518, 2022 05 04.
Artigo em Inglês | MEDLINE | ID: mdl-34791217

RESUMO

Mutations in the mitochondrial protein CHCHD2 cause autosomal dominant Parkinson's disease characterized by the preferential loss of substantia nigra dopamine (DA) neurons. Therefore, understanding the function of CHCHD2 in neurons may provide vital insights into how mitochondrial dysfunction contributes to neurodegeneration in PD. To investigate the normal requirement and function of CHCHD2 in neurons, we first examined CHCHD2 levels and showed that DA neurons have higher CHCHD2 levels than other neuron types, both in vivo and in co-culture. We then generated mice with either a targeted deletion of CHCHD2 in DA neurons or a deletion in the brain or total body. All three models were viable, and loss of CHCHD2 in the brain did not cause degeneration of DA neurons. Mice lacking CHCHD2 in DA neurons did display sex-specific changes to locomotor activity, but we did not observe differences in assays of muscle strength, exercise endurance or motor coordination. Furthermore, mitochondria derived from mice lacking CHCHD2 did not display abnormalities in OXPHOS function. Lastly, resilience to CHCHD2 deletion could not be explained by functional complementation by its paralog CHCHD10, as deletion of both CHCHD10 and CHCHD2 did not cause degeneration of DA neurons in the midbrain. These findings support the hypothesis that pathogenic CHCHD2 mutations cause PD through a toxic gain-of-function, rather than loss-of-function mechanism.


Assuntos
Neurônios Dopaminérgicos , Proteínas Mitocondriais , Animais , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Neurônios Dopaminérgicos/metabolismo , Feminino , Masculino , Camundongos , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/metabolismo , Substância Negra/metabolismo , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo
3.
Sci Adv ; 7(32)2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34362731

RESUMO

Altered mitochondrial quality control and dynamics may contribute to neurodegenerative diseases, including Parkinson's disease, but we understand little about these processes in neurons. We combined time-lapse microscopy and correlative light and electron microscopy to track individual mitochondria in neurons lacking the fission-promoting protein dynamin-related protein 1 (Drp1) and delineate the kinetics of PINK1-dependent pathways of mitochondrial quality control. Depolarized mitochondria recruit Parkin to the outer mitochondrial membrane, triggering autophagosome formation, rapid lysosomal fusion, and Parkin redistribution. Unexpectedly, these mitolysosomes are dynamic and persist for hours. Some are engulfed by healthy mitochondria, and others are deacidified before bursting. In other cases, Parkin is directly recruited to the matrix of polarized mitochondria. Loss of PINK1 blocks Parkin recruitment, causes LC3 accumulation within mitochondria, and exacerbates Drp1KO toxicity to dopamine neurons. These results define a distinct neuronal mitochondrial life cycle, revealing potential mechanisms of mitochondrial recycling and signaling relevant to neurodegeneration.

4.
Nat Commun ; 11(1): 4319, 2020 08 28.
Artigo em Inglês | MEDLINE | ID: mdl-32859923

RESUMO

Disrupted energy metabolism drives cell dysfunction and disease, but approaches to increase or preserve ATP are lacking. To generate a comprehensive metabolic map of genes and pathways that regulate cellular ATP-the ATPome-we conducted a genome-wide CRISPR interference/activation screen integrated with an ATP biosensor. We show that ATP level is modulated by distinct mechanisms that promote energy production or inhibit consumption. In our system HK2 is the greatest ATP consumer, indicating energy failure may not be a general deficiency in producing ATP, but rather failure to recoup the ATP cost of glycolysis and diversion of glucose metabolites to the pentose phosphate pathway. We identify systems-level reciprocal inhibition between the HIF1 pathway and mitochondria; glycolysis-promoting enzymes inhibit respiration even when there is no glycolytic ATP production, and vice versa. Consequently, suppressing alternative metabolism modes paradoxically increases energy levels under substrate restriction. This work reveals mechanisms of metabolic control, and identifies therapeutic targets to correct energy failure.


Assuntos
Trifosfato de Adenosina/metabolismo , Redes e Vias Metabólicas/genética , Redes e Vias Metabólicas/fisiologia , Trifosfato de Adenosina/genética , Sistemas CRISPR-Cas , Linhagem Celular , Metabolismo Energético , Feminino , Fibroblastos , Regulação da Expressão Gênica , Técnicas de Silenciamento de Genes , Glucose/metabolismo , Glicólise/fisiologia , Hexoquinase/genética , Hexoquinase/metabolismo , Humanos , Células K562 , Metabolômica , Mitocôndrias/metabolismo , Via de Pentose Fosfato , Mutação Puntual
5.
PLoS Biol ; 16(8): e2004624, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-30148842

RESUMO

Insufficient or dysregulated energy metabolism may underlie diverse inherited and degenerative diseases, cancer, and even aging itself. ATP is the central energy carrier in cells, but critical pathways for regulating ATP levels are not systematically understood. We combined a pooled clustered regularly interspaced short palindromic repeats interference (CRISPRi) library enriched for mitochondrial genes, a fluorescent biosensor, and fluorescence-activated cell sorting (FACS) in a high-throughput genetic screen to assay ATP concentrations in live human cells. We identified genes not known to be involved in energy metabolism. Most mitochondrial ribosomal proteins are essential in maintaining ATP levels under respiratory conditions, and impaired respiration predicts poor growth. We also identified genes for which coenzyme Q10 (CoQ10) supplementation rescued ATP deficits caused by knockdown. These included CoQ10 biosynthetic genes associated with human disease and a subset of genes not linked to CoQ10 biosynthesis, indicating that increasing CoQ10 can preserve ATP in specific genetic contexts. This screening paradigm reveals mechanisms of metabolic control and genetic defects responsive to energy-based therapies.


Assuntos
Trifosfato de Adenosina/análise , Metabolismo Energético/fisiologia , Ensaios de Triagem em Larga Escala/métodos , Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas , Humanos , Mitocôndrias/genética , Mitocôndrias/metabolismo , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/metabolismo , Análise de Célula Única/métodos , Ubiquinona/análogos & derivados , Ubiquinona/metabolismo
6.
eNeuro ; 4(2)2017.
Artigo em Inglês | MEDLINE | ID: mdl-28462393

RESUMO

Increased α-synuclein (αsyn) and mitochondrial dysfunction play central roles in the pathogenesis of Parkinson's disease (PD), and lowering αsyn is under intensive investigation as a therapeutic strategy for PD. Increased αsyn levels disrupt mitochondria and impair respiration, while reduced αsyn protects against mitochondrial toxins, suggesting that interactions between αsyn and mitochondria influences the pathologic and physiologic functions of αsyn. However, we do not know if αsyn affects normal mitochondrial function or if lowering αsyn levels impacts bioenergetic function, especially at the nerve terminal where αsyn is enriched. To determine if αsyn is required for normal mitochondrial function in neurons, we comprehensively evaluated how lowering αsyn affects mitochondrial function. We found that αsyn knockout (KO) does not affect the respiration of cultured hippocampal neurons or cortical and dopaminergic synaptosomes, and that neither loss of αsyn nor all three (α, ß and γ) syn isoforms decreased mitochondria-derived ATP levels at the synapse. Similarly, neither αsyn KO nor knockdown altered the capacity of synaptic mitochondria to meet the energy requirements of synaptic vesicle cycling or influenced the localization of mitochondria to dopamine (DA) synapses in vivo. Finally, αsyn KO did not affect overall energy metabolism in mice assessed with a Comprehensive Lab Animal Monitoring System. These studies suggest either that αsyn has little or no significant physiological effect on mitochondrial bioenergetic function, or that any such functions are fully compensated for when lost. These results implicate that αsyn levels can be reduced in neurons without impairing (or improving) mitochondrial bioenergetics or distribution.


Assuntos
Mitocôndrias/metabolismo , Neurônios/metabolismo , Sinapses/metabolismo , alfa-Sinucleína/metabolismo , Animais , Dopamina/metabolismo , Hipocampo/metabolismo , Camundongos Knockout , Doença de Parkinson/metabolismo , alfa-Sinucleína/deficiência , alfa-Sinucleína/genética
7.
Artigo em Inglês | MEDLINE | ID: mdl-27294417

RESUMO

Interest is growing in a disinfection technique for water treatment without disinfection byproducts. This study presents the result of using a liquid-film-forming apparatus at less than 1.0 MPa for disinfection of seawater. The sensitivity of Enterococcus sp. (ATCC 202155) to the pressurized carbon dioxide (CO2) was examined under various conditions of pressure cycling, pressure, working volume ratio (WVR), and CO2 content rate. The key influences on frequency and magnitude of pressure cycling in enhancing Enterococcus sp. inactivation are elucidated. The results reveal strong correlation between pressure cycling and inactivation efficiency (P-value < 0.001). The outcome of linear regression model analysis suggests that the model can explain 93%, 85%, and 89% of the inactivation efficiency of (25% CO2 + 75% N2), (50% CO2 + 50% N2), and 100% CO2, respectively. The predicted value was fit with experimental results (p-value <0.05). Under identical treatment conditions (pressure = 0.9 MPa, ΔP = 0.14 MPa, 70% WVR, and 20 ± 1°C), treatment with pressurized CO2 (100% purity) resulted in complete inactivation 5.2 log of Enterococcus sp. after 70 cycles within 20 min. The Enterococcus sp. inactivation of pressurized CO2 followed first-order reaction kinetics. The smallest D-value (largest k-value) was induced by pressurized CO2 (100% purity) at 0.9 MPa, which was obtained at 3.85 min (0.5988 min(-1), R(2) ≥ 0.95). The findings could provide an effective method for enhanced bactericidal performance of pressurized CO2, to address recently emerging problems in water disinfection.


Assuntos
Dióxido de Carbono/química , Desinfecção/métodos , Enterococcus/crescimento & desenvolvimento , Pressão , Água do Mar/microbiologia , Contagem de Colônia Microbiana , Enterococcus/efeitos dos fármacos , Modelos Lineares , Purificação da Água
8.
Artigo em Inglês | MEDLINE | ID: mdl-26737733

RESUMO

The concept of Compton camera originates from the need to improve sensitivity in Single Photon Emission Imaging, which uses hole collimators. It advocates electronic collimation which registers radiation emitted by the radiating object and scattered by a scattering detector placed before an absorption detector. The data consists of three dimensional conical projections of the activity density of a radio-tracer. An analytic reconstruction method of this density is presently not available. To evaluate its imaging power, we consider a particular two-dimensional Compton camera in which the collected data consists of the set of integrals of the density on rotating V-lines. In this communication, we present simulation results obtained from an algebraic reconstruction technique, which illustrate and validate the imaging capability of this Compton camera modality.


Assuntos
Tomografia Computadorizada de Emissão de Fóton Único/instrumentação , Algoritmos , Humanos , Imagens de Fantasmas , Glândula Tireoide/anatomia & histologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...